These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7027470)

  • 21. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
    Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
    Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of adult patients with aplastic anemia in Japan].
    Urabe A; Ichiki S; Usukine K; Ijima K
    Rinsho Ketsueki; 2005 Jun; 46(6):389-93. PubMed ID: 16447719
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aplastic anemia--treatment].
    Schroers R; Hohloch K; Trümper L
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1841-4; quiz 1845-6. PubMed ID: 12964104
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].
    Uss AL; Zmachinskiĭ VA; Milanovich NF; Skriagin AE; Batan ZE; Dziuba EV; Mitskevich PB; Smirnova LA
    Ter Arkh; 1999; 71(7):69-72. PubMed ID: 10481871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of bone marrow transfusions in the complex treatment of hypo and aplastic anemias].
    Daskalov A; Osmanlijev P; Nikolov T; Kurtewa B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):445-51. PubMed ID: 4184470
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current methods of treatment of patients with hypo- and aplastic anemia].
    Sherman SI; Rozanova LM; Abdulkadyrov KM; Povergo NS; Rafal'son DI; Senchilo EA
    Probl Gematol Pereliv Krovi; 1966 Jun; 11(6):16-9. PubMed ID: 4866623
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antilymphocyte globulin as an immunodepressive agent in histocompatible allomyelografts].
    Liubimova LS; Umbetkulova EK; Poreshina LP; Tananov AT; Udovichenko AI
    Probl Gematol Pereliv Krovi; 1980 Jun; 25(6):15-8. PubMed ID: 6994089
    [No Abstract]   [Full Text] [Related]  

  • 28. Aplastic anaemia: continued cause for concern.
    Webb DK
    Arch Dis Child; 1990 Oct; 65(10):1105-6. PubMed ID: 2248498
    [No Abstract]   [Full Text] [Related]  

  • 29. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
    Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
    Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of severe aplastic anemia].
    Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An introduction to clinical decision analysis: bone marrow transplantation for aplastic anemia.
    Flecknoe-Brown S
    Aust N Z J Med; 1984 Oct; 14(5):685-6. PubMed ID: 6397180
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment and prognosis of aplastic anemia].
    Hiraki K; Mori S
    Saishin Igaku; 1969 Apr; 24(4):749-56. PubMed ID: 4185455
    [No Abstract]   [Full Text] [Related]  

  • 33. [Autoimmune pancytopenia, aplastic anemia].
    Urabe A
    Ryoikibetsu Shokogun Shirizu; 2000; (31):165-7. PubMed ID: 11269047
    [No Abstract]   [Full Text] [Related]  

  • 34. [The treatment of the aplastic syndromes].
    Gross R; Hellriegel KP; Zach J
    Internist (Berl); 1971 Apr; 12(4):186-91. PubMed ID: 4928641
    [No Abstract]   [Full Text] [Related]  

  • 35. [Algorithm for treatment of acquired aplastic anemia].
    Kojima S
    Rinsho Ketsueki; 2009 Jul; 50(7):532-7. PubMed ID: 19638720
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aplastic anemia. Alternative treatment by bone marrow transplantation].
    Fonseca T; Raposo J; Gomez B; d'Oliveira JJ; de Lacerda JM
    Acta Med Port; 1997 Jan; 10(1):99-102. PubMed ID: 9245186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].
    Mikhaĭlova EA; Iadrikhinskaia VN; Savchenko VG
    Ter Arkh; 1999; 71(7):64-9. PubMed ID: 10481870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Theapy of panmyelopathy].
    Lutz H; Hartwich G
    Med Klin; 1973 Jun; 68(23):761-4. PubMed ID: 4579459
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.